SNTA1
SNTA1 (syntrophin alpha 1, also known as alpha-1-syntrophin, TACIP1, LQT12 and SNT1) is a PDZ domain-containing adapter protein of the dystrophin-associated protein complex. It organises membrane proteins at the sarcolemma and neuromuscular synapse, and is the most common syntrophin isoform in cardiac tissue. Browse Assay Genie's current range of SNTA1 research reagents below, or read on for the biology behind the target.
SNTA1 is an adapter protein that binds to, and probably organises the subcellular localisation of, a variety of membrane proteins. It may link receptors to the actin cytoskeleton and the extracellular matrix through the dystrophin glycoprotein complex. It plays an important role in synapse formation and in the organisation of UTRN (utrophin) and acetylcholine receptors at the neuromuscular synapse, and it binds phosphatidylinositol 4,5-bisphosphate.
Syntrophins are cytoplasmic peripheral membrane scaffold proteins, and the SNTA1 gene is a member of the syntrophin gene family. It encodes the most common syntrophin isoform in cardiac tissue. Its N-terminal PDZ domain interacts with the C-terminus of SCN5A, the pore-forming alpha subunit of the cardiac sodium channel Nav1.5. The protein also associates cardiac sodium channels with the nitric oxide synthase-PMCA4b (plasma membrane Ca-ATPase subtype 4b) complex in cardiomyocytes. At the neuromuscular junction it associates with dystrophin and dystrophin-related proteins, and it alters intracellular calcium ion levels in muscle tissue. It localises to the sarcolemma, cell junctions and the cytoskeleton.
The gene is a susceptibility locus for Long-QT syndrome (LQT), an inherited disorder associated with sudden cardiac death from arrhythmia, and for sudden infant death syndrome (SIDS). This disease link explains the alias LQT12. The earlier HGNC name described it as syntrophin, alpha 1 (dystrophin-associated protein A1, 59kD, acidic component), and SNT1 and TACIP1 are other names in use.
SNTA1 binds the Nav1.5 subunit SCN5A through its PDZ domain, making it relevant to how sodium channels are organised in cardiomyocytes.
The SNTA1 gene is a susceptibility locus for Long-QT syndrome, an inherited disorder linked to sudden cardiac death from arrhythmia.
SNTA1 helps organise UTRN and acetylcholine receptors at the neuromuscular synapse and associates with dystrophin and related proteins.
As a component of the dystrophin-associated protein complex, SNTA1 alters intracellular calcium levels in muscle and links to the nitric oxide synthase-PMCA4b complex.
SNTA1 is an adapter protein that binds and probably organises the localisation of membrane proteins. It may link receptors to the actin cytoskeleton and extracellular matrix via the dystrophin glycoprotein complex, and it helps organise UTRN and acetylcholine receptors at the neuromuscular synapse.
SNTA1 stands for syntrophin alpha 1 and the protein is called alpha-1-syntrophin. Aliases include TACIP1, LQT12 and SNT1. An earlier HGNC name was syntrophin, alpha 1 (dystrophin-associated protein A1, 59kD, acidic component).
Yes. The SNTA1 gene is a susceptibility locus for Long-QT syndrome, an inherited disorder associated with sudden cardiac death from arrhythmia, and for sudden infant death syndrome. A mouse ortholog, Snta1, exists; check the datasheet of any product for its validated reactivity.
Other syntrophins, dystrophin-associated complex components and cardiac ion channel partners that link to SNTA1 biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13424; product specifications from Assay Genie datasheets.